APO Research
Talk to an analyst

APO RESEARCH · REPORT

Covid-19 Serology Testing

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

Selected research

Market Outlook & Growth Opportunities

Global Covid-19 Serology Testing Market Outlook and Growth Opportunities 2026

28 December 2025198 pages

Choose your research edition.

Industry ResearchCovid-19 Serology Testing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Covid-19 Serology Testing Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Covid-19 Serology Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Covid-19 Serology Testing Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Covid-19 Serology Testing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Serology tests are blood-based tests that can be used to identify whether people have been exposed to a particular pathogen by looking at their immune response.These tests can give greater detail into the prevalence of a disease in a population by identifying individuals who have developed antibodies to the virus.

North America is the largest consumption place, with a consumption market share nearly 35.21% in 2020. APAC is the second largest consumption place with the consumption market share of 32.43%.

Market competition is intense. Abbott, Guangzhou Wondfo Biotech, BioMedomics, Kantaro, Roche, etc. are the leaders of the industry. The top 5 companies occupied about half of the market in 2019.

Read the full market overview

Among the classification of Covid-19 Serology Testing, the proportion of Chemiluminescent Immunoassay in 2020 is about 73.45%.

Covid-19 Serology Testing is widely used for Hospitals and Third-party laboratory. The most proportion of Covid-19 Serology Testing is Hospitals, and the proportion in 2020 is 52.47%.

This report provides an overview of the global Covid-19 Serology Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Covid-19 Serology Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Covid-19 Serology Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Covid-19 Serology Testing market.

Covid-19 Serology Testing Segment by Company

Abbott

Guangzhou Wondfo Biotech

BioMedomics

Kantaro

Roche

Cellex

Innovita Biological Technology

Zhejiang Orient Gene Biotech

Ortho Clinical Diagnostics

Guangdong Hecin-Scientific

Dynamiker Biotechnology (Tianjin)

Chembio Diagnostics

Safecare Bio-Tech

Covid-19 Serology Testing Segment by Type

Rapid Diagnostic Test (RDT)

Chemiluminescent Immunoassay

Other

Covid-19 Serology Testing Segment by Application

Hospitals

Third-party laboratory

Covid-19 Serology Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Covid-19 Serology Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Covid-19 Serology Testing key companies, revenue, market share, and recent developments.

3. To split the Covid-19 Serology Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Covid-19 Serology Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Covid-19 Serology Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Covid-19 Serology Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Serology Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Covid-19 Serology Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Serology Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Covid-19 Serology Testing industry.

Chapter 3: Detailed analysis of Covid-19 Serology Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Covid-19 Serology Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Covid-19 Serology Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Covid-19 Serology Testing Industry Trends Table 2. Covid-19 Serology Testing Industry Drivers Table 3. Covid-19 Serology Testing Industry Opportunities and Challenges Table 4. Covid-19 Serology Testing Industry Restraints Table 5. Global Covid-19 Serology Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Covid-19 Serology Testing Revenue Share by Company (2021-2026) Table 7. Global Covid-19 Serology Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Covid-19 Serology Testing Key Company Manufacturing Base & Headquarters Table 9. Global Covid-19 Serology Testing Company, Product Type & Application Table 10. Global Covid-19 Serology Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Covid-19 Serology Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Rapid Diagnostic Test (RDT) Table 15. Significant Companies of Chemiluminescent Immunoassay Table 16. Significant Companies of Other Table 17. Global Covid-19 Serology Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Covid-19 Serology Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Covid-19 Serology Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Covid-19 Serology Testing Sales Value Share by Type (2021-2026) Table 21. Global Covid-19 Serology Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Third-party laboratory Table 24. Global Covid-19 Serology Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Covid-19 Serology Testing Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Covid-19 Serology Testing Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Covid-19 Serology Testing Sales Value Share by Application (2021-2026) Table 28. Global Covid-19 Serology Testing Sales Value Share by Application (2027-2032) Table 29. Global Covid-19 Serology Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Covid-19 Serology Testing Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Covid-19 Serology Testing Sales Value Share by Region (2021-2026) Table 32. Global Covid-19 Serology Testing Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Covid-19 Serology Testing Sales Value Share by Region (2027-2032) Table 34. Global Covid-19 Serology Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Covid-19 Serology Testing Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Covid-19 Serology Testing Sales Value Market Share by Country (2021-2026) Table 37. Global Covid-19 Serology Testing Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Covid-19 Serology Testing Sales Value Market Share by Country (2027-2032) Table 39. Abbott Company Information Table 40. Abbott Business Overview Table 41. Abbott Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Abbott Covid-19 Serology Testing Product Portfolio Table 43. Abbott Recent Development Table 44. Guangzhou Wondfo Biotech Company Information Table 45. Guangzhou Wondfo Biotech Business Overview Table 46. Guangzhou Wondfo Biotech Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Guangzhou Wondfo Biotech Covid-19 Serology Testing Product Portfolio Table 48. Guangzhou Wondfo Biotech Recent Development Table 49. BioMedomics Company Information Table 50. BioMedomics Business Overview Table 51. BioMedomics Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. BioMedomics Covid-19 Serology Testing Product Portfolio Table 53. BioMedomics Recent Development Table 54. Kantaro Company Information Table 55. Kantaro Business Overview Table 56. Kantaro Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Kantaro Covid-19 Serology Testing Product Portfolio Table 58. Kantaro Recent Development Table 59. Roche Company Information Table 60. Roche Business Overview Table 61. Roche Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Roche Covid-19 Serology Testing Product Portfolio Table 63. Roche Recent Development Table 64. Cellex Company Information Table 65. Cellex Business Overview Table 66. Cellex Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cellex Covid-19 Serology Testing Product Portfolio Table 68. Cellex Recent Development Table 69. Innovita Biological Technology Company Information Table 70. Innovita Biological Technology Business Overview Table 71. Innovita Biological Technology Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Innovita Biological Technology Covid-19 Serology Testing Product Portfolio Table 73. Innovita Biological Technology Recent Development Table 74. Zhejiang Orient Gene Biotech Company Information Table 75. Zhejiang Orient Gene Biotech Business Overview Table 76. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product Portfolio Table 78. Zhejiang Orient Gene Biotech Recent Development Table 79. Ortho Clinical Diagnostics Company Information Table 80. Ortho Clinical Diagnostics Business Overview Table 81. Ortho Clinical Diagnostics Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Ortho Clinical Diagnostics Covid-19 Serology Testing Product Portfolio Table 83. Ortho Clinical Diagnostics Recent Development Table 84. Guangdong Hecin-Scientific Company Information Table 85. Guangdong Hecin-Scientific Business Overview Table 86. Guangdong Hecin-Scientific Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Guangdong Hecin-Scientific Covid-19 Serology Testing Product Portfolio Table 88. Guangdong Hecin-Scientific Recent Development Table 89. Dynamiker Biotechnology (Tianjin) Company Information Table 90. Dynamiker Biotechnology (Tianjin) Business Overview Table 91. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product Portfolio Table 93. Dynamiker Biotechnology (Tianjin) Recent Development Table 94. Chembio Diagnostics Company Information Table 95. Chembio Diagnostics Business Overview Table 96. Chembio Diagnostics Covid-19 Serology Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Chembio Diagnostics Covid-19 Serology Testing Product Portfolio Table 98. Chembio Diagnostics Recent Development Table 99. Safecare Bio-Tech Company Information Table 100. Safecare Bio-Tech Business Overview Table 101. Safecare Bio-Tech Covid-19 Serology Testing Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Safecare Bio-Tech Covid-19 Serology Testing Product Portfolio Table 103. Safecare Bio-Tech Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Covid-19 Serology Testing Product Image Figure 2. Global Covid-19 Serology Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Covid-19 Serology Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Covid-19 Serology Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Rapid Diagnostic Test (RDT) Image Figure 8. Chemiluminescent Immunoassay Image Figure 9. Other Image Figure 10. Global Covid-19 Serology Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Covid-19 Serology Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Covid-19 Serology Testing Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Third-party laboratory Image Figure 15. Global Covid-19 Serology Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Covid-19 Serology Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Covid-19 Serology Testing Sales Value Share by Application (2021-2032) Figure 18. Global Covid-19 Serology Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Covid-19 Serology Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Covid-19 Serology Testing Sales Value (2021-2032) & (US$ Million) Figure 21. North America Covid-19 Serology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Covid-19 Serology Testing Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Covid-19 Serology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Covid-19 Serology Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Covid-19 Serology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Covid-19 Serology Testing Sales Value (2021-2032) & (US$ Million) Figure 27. South America Covid-19 Serology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Covid-19 Serology Testing Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Covid-19 Serology Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Covid-19 Serology Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Rapid Diagnostic Test (RDT)
  • Chemiluminescent Immunoassay
  • Other
Applications
  • Hospitals
  • Third-party laboratory
Companies covered
  • Abbott
  • Guangzhou Wondfo Biotech
  • BioMedomics
  • Kantaro
  • Roche
  • Cellex
  • Innovita Biological Technology
  • Zhejiang Orient Gene Biotech
  • Ortho Clinical Diagnostics
  • Guangdong Hecin-Scientific
  • Dynamiker Biotechnology (Tianjin)
  • Chembio Diagnostics
  • Safecare Bio-Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Covid-19 Serology Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Covid-19 Serology Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Covid-19 Serology Testing Market Dynamics
  1. 2.1 Covid-19 Serology Testing Industry Trends
  2. 2.2 Covid-19 Serology Testing Industry Drivers
  3. 2.3 Covid-19 Serology Testing Industry Opportunities and Challenges
  4. 2.4 Covid-19 Serology Testing Industry Restraints
3 Covid-19 Serology Testing Market by Company
  1. 3.1 Global Covid-19 Serology Testing Company Revenue Ranking in 2025
  2. 3.2 Global Covid-19 Serology Testing Revenue by Company (2021-2026)
  3. 3.3 Global Covid-19 Serology Testing Company Ranking (2024-2026)
  4. 3.4 Global Covid-19 Serology Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Covid-19 Serology Testing Company Product Type and Application
  6. 3.6 Global Covid-19 Serology Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Covid-19 Serology Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Covid-19 Serology Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Covid-19 Serology Testing Market by Type
  1. 4.1 Covid-19 Serology Testing Type Introduction
  2. 4.1.1 Rapid Diagnostic Test (RDT)
  3. 4.1.2 Chemiluminescent Immunoassay
  4. 4.1.3 Other
  5. 4.2 Global Covid-19 Serology Testing Sales Value by Type
  6. 4.2.1 Global Covid-19 Serology Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Covid-19 Serology Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Covid-19 Serology Testing Sales Value Share by Type (2021-2032)
5 Covid-19 Serology Testing Market by Application
  1. 5.1 Covid-19 Serology Testing Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Third-party laboratory
  4. 5.2 Global Covid-19 Serology Testing Sales Value by Application
  5. 5.2.1 Global Covid-19 Serology Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Covid-19 Serology Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Covid-19 Serology Testing Sales Value Share by Application (2021-2032)
6 Covid-19 Serology Testing Regional Value Analysis
  1. 6.1 Global Covid-19 Serology Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Covid-19 Serology Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Covid-19 Serology Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Covid-19 Serology Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Covid-19 Serology Testing Sales Value (2021-2032)
  7. 6.3.2 North America Covid-19 Serology Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Covid-19 Serology Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Covid-19 Serology Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Covid-19 Serology Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Covid-19 Serology Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Covid-19 Serology Testing Sales Value (2021-2032)
  16. 6.6.2 South America Covid-19 Serology Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Covid-19 Serology Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Covid-19 Serology Testing Sales Value Share by Country, 2025 VS 2032
7 Covid-19 Serology Testing Country-level Value Analysis
  1. 7.1 Global Covid-19 Serology Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Covid-19 Serology Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Covid-19 Serology Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Covid-19 Serology Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Covid-19 Serology Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Covid-19 Serology Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Covid-19 Serology Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Covid-19 Serology Testing Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Guangzhou Wondfo Biotech
  8. 8.2.1 Guangzhou Wondfo Biotech Company Information
  9. 8.2.2 Guangzhou Wondfo Biotech Business Overview
  10. 8.2.3 Guangzhou Wondfo Biotech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Guangzhou Wondfo Biotech Covid-19 Serology Testing Product Portfolio
  12. 8.2.5 Guangzhou Wondfo Biotech Recent Developments
  13. 8.3 BioMedomics
  14. 8.3.1 BioMedomics Company Information
  15. 8.3.2 BioMedomics Business Overview
  16. 8.3.3 BioMedomics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BioMedomics Covid-19 Serology Testing Product Portfolio
  18. 8.3.5 BioMedomics Recent Developments
  19. 8.4 Kantaro
  20. 8.4.1 Kantaro Company Information
  21. 8.4.2 Kantaro Business Overview
  22. 8.4.3 Kantaro Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Kantaro Covid-19 Serology Testing Product Portfolio
  24. 8.4.5 Kantaro Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Covid-19 Serology Testing Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 Cellex
  32. 8.6.1 Cellex Company Information
  33. 8.6.2 Cellex Business Overview
  34. 8.6.3 Cellex Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cellex Covid-19 Serology Testing Product Portfolio
  36. 8.6.5 Cellex Recent Developments
  37. 8.7 Innovita Biological Technology
  38. 8.7.1 Innovita Biological Technology Company Information
  39. 8.7.2 Innovita Biological Technology Business Overview
  40. 8.7.3 Innovita Biological Technology Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Innovita Biological Technology Covid-19 Serology Testing Product Portfolio
  42. 8.7.5 Innovita Biological Technology Recent Developments
  43. 8.8 Zhejiang Orient Gene Biotech
  44. 8.8.1 Zhejiang Orient Gene Biotech Company Information
  45. 8.8.2 Zhejiang Orient Gene Biotech Business Overview
  46. 8.8.3 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product Portfolio
  48. 8.8.5 Zhejiang Orient Gene Biotech Recent Developments
  49. 8.9 Ortho Clinical Diagnostics
  50. 8.9.1 Ortho Clinical Diagnostics Company Information
  51. 8.9.2 Ortho Clinical Diagnostics Business Overview
  52. 8.9.3 Ortho Clinical Diagnostics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Ortho Clinical Diagnostics Covid-19 Serology Testing Product Portfolio
  54. 8.9.5 Ortho Clinical Diagnostics Recent Developments
  55. 8.10 Guangdong Hecin-Scientific
  56. 8.10.1 Guangdong Hecin-Scientific Company Information
  57. 8.10.2 Guangdong Hecin-Scientific Business Overview
  58. 8.10.3 Guangdong Hecin-Scientific Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Guangdong Hecin-Scientific Covid-19 Serology Testing Product Portfolio
  60. 8.10.5 Guangdong Hecin-Scientific Recent Developments
  61. 8.11 Dynamiker Biotechnology (Tianjin)
  62. 8.11.1 Dynamiker Biotechnology (Tianjin) Company Information
  63. 8.11.2 Dynamiker Biotechnology (Tianjin) Business Overview
  64. 8.11.3 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product Portfolio
  66. 8.11.5 Dynamiker Biotechnology (Tianjin) Recent Developments
  67. 8.12 Chembio Diagnostics
  68. 8.12.1 Chembio Diagnostics Company Information
  69. 8.12.2 Chembio Diagnostics Business Overview
  70. 8.12.3 Chembio Diagnostics Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Chembio Diagnostics Covid-19 Serology Testing Product Portfolio
  72. 8.12.5 Chembio Diagnostics Recent Developments
  73. 8.13 Safecare Bio-Tech
  74. 8.13.1 Safecare Bio-Tech Company Information
  75. 8.13.2 Safecare Bio-Tech Business Overview
  76. 8.13.3 Safecare Bio-Tech Covid-19 Serology Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Safecare Bio-Tech Covid-19 Serology Testing Product Portfolio
  78. 8.13.5 Safecare Bio-Tech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst